Pharose Remedies Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 13-11-2024
- Paid Up Capital ₹ 2.00 Cr
as on 13-11-2024
- Company Age 27 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 19.17 Cr
as on 13-11-2024
- Satisfied Charges ₹ 18.60 Cr
as on 13-11-2024
- Revenue -1.85%
(FY 2023)
- Profit -20.03%
(FY 2023)
- Ebitda -12.39%
(FY 2023)
- Net Worth 34.21%
(FY 2023)
- Total Assets 5.38%
(FY 2023)
About Pharose Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹19.17 Cr. The company has closed loans amounting to ₹18.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nand Jain, Pardeep Jain, and Ram Chandara serve as directors at the Company.
- CIN/LLPIN
U24239PB1997PLC020673
- Company No.
020673
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Nov 1997
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- LocationPunjab, Punjab
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Pharose Remedies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pardeep Jain  | Managing Director | 18-Nov-1997 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nand Jain | Whole-Time Director | 18-Nov-1997 | Current |
| Ram Chandara | Whole-Time Director | 01-Apr-2005 | Current |
Financial Performance of Pharose Remedies.
Pharose Remedies Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 1.85% decrease. The company also saw a substantial fall in profitability, with a 20.03% decrease in profit. The company's net worth Soared by an impressive increase of 34.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharose Remedies?
In 2023, Pharose Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pharose Hospitality Private LimitedActive 30 years 7 monthsNand Jain and Pardeep Jain are mutual person
- Pharose Remedies (Unit-Ii) Private LimitedActive 1 year 22 days
Nand Jain and Pardeep Jain are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Apr 2024 | ₹9.00 M | Open |
Others Creation Date: 06 Aug 2022 | ₹1.19 M | Open |
Hdfc Bank Limited Creation Date: 31 Dec 2019 | ₹18.15 Cr | Open |
How Many Employees Work at Pharose Remedies?
Unlock and access historical data on people associated with Pharose Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharose Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharose Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
